ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,650.45
      0.34%
      US Tech 100
      19,757.20
      -0.45%
      Dow Jones
      40,804.24
      1.47%
      Brent Oil
      83.355
      -1.17%
      Bitcoin
      64,418.98
      -0.69%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Antares Pharma Inc (ATRS)

      7. Antares Pharma Inc (ATRS) News

      ATRS

      Antares Pharma (ATRS)

      Antares Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRS
      DateTimeSourceHeadlineSymbolCompany
      02/15/20187:00AMGlobeNewswire Inc.Antares Pharma Announces FDA Approval of Partner’s Product Utilizing Our QuickShot Auto InjectorNASDAQ:ATRSAntares Pharma Inc
      02/14/20186:21PMGlobeNewswire Inc.Antares Pharma Announces FDA Approval of Partner’s Product Utilizing Our QuickShot Auto InjectorNASDAQ:ATRSAntares Pharma Inc
      02/14/20186:03PMGlobeNewswire Inc.AMAG Pharmaceuticals Announces FDA Approval of Makena® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector t...NASDAQ:ATRSAntares Pharma Inc
      02/14/201810:42AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRSAntares Pharma Inc
      02/13/20184:43PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRSAntares Pharma Inc
      02/01/20189:29AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ATRSAntares Pharma Inc
      02/01/20188:05AMInvestorsHub NewsWireTraders News Source Identifies four stocks to add to your Watch list Plus Feature Cannabis and Block-chain ReportNASDAQ:ATRSAntares Pharma Inc
      01/16/20187:00AMGlobeNewswire Inc.Antares Pharma Provides XYOSTED™ Regulatory UpdateNASDAQ:ATRSAntares Pharma Inc
      12/21/20174:01PMGlobeNewswire Inc.Antares Pharma Provides XYOSTED™ Regulatory UpdateNASDAQ:ATRSAntares Pharma Inc
      12/20/20178:00AMGlobeNewswire Inc.New Patent Issued to AMAG Pharmaceuticals Entitled "Methods of Reducing Risk of Preterm Birth"NASDAQ:ATRSAntares Pharma Inc
      11/07/20174:55PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
      11/07/20177:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      11/07/20177:00AMGlobeNewswire Inc.Antares Pharma Reports Third Quarter 2017 Operating and Financial ResultsNASDAQ:ATRSAntares Pharma Inc
      10/31/20177:00AMGlobeNewswire Inc.Antares Pharma to Report Third Quarter 2017 Financial and Operating Results and Host Webcast and Conference CallNASDAQ:ATRSAntares Pharma Inc
      10/23/20176:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      10/20/20176:49PMGlobeNewswire Inc.Antares Pharma Receives Complete Response Letter From the FDA for XYOSTED™NASDAQ:ATRSAntares Pharma Inc
      10/12/20175:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      10/12/20175:00PMGlobeNewswire Inc.Antares Pharma Provides XYOSTED™ Regulatory UpdateNASDAQ:ATRSAntares Pharma Inc
      10/11/20175:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      10/10/20174:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      10/10/20177:00AMGlobeNewswire Inc.Antares Pharma Announces Sale of ZOMAJET™ Needle-Free Delivery System to Ferring PharmaceuticalsNASDAQ:ATRSAntares Pharma Inc
      10/05/20175:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      09/20/20178:40AMGlobeNewswire Inc.Antares Pharma to Present at the Ladenburg Thalmann 2017 Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      09/05/20177:00AMGlobeNewswire Inc.Antares Pharma to Present at the Rodman & Renshaw 19th Annual Global Investment ConferenceNASDAQ:ATRSAntares Pharma Inc
      08/11/20174:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      08/11/20174:19PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ATRSAntares Pharma Inc
      08/09/20178:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      08/08/20174:31PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
      08/08/20177:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      08/08/20177:00AMGlobeNewswire Inc.Antares Pharma Reports Second Quarter 2017 Operating And Financial ResultsNASDAQ:ATRSAntares Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:ATRS